Prognostic significance of NAB2-STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear

2019-04-01

Acta Neuropathologica , Volume 137 - Issue 4 p. 679- 682

Additional Metadata
Persistent URL	doi.org/10.1007/s00401-019-01968-3, hdl.handle.net/1765/116315
Series	VSNU Open Access deal
Journal	Acta Neuropathologica
Note	corresponding author at Radboud
Organisation	Department of Neurosurgery
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vogels, R., Macagno, N., Griewank, K., Groenen, P., Verdijk, M., Fonville, J., Küsters, B., Figarella-Branger, D., Wesseling, P., Bouvier, C., Flucke, U., Cornu, P., Dufour, H., Guyotat, J., Jouvet, A., Metellus, P., Mokhtari, K., Vasiljevic, A, Varlet, P, … van Furth, W. (2019). Prognostic significance of NAB2-STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear. Acta Neuropathologica, 137(4), 679–682.https://doi.org/10.1007/s00401-019-01968-3

Publication